FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

(MedPage Today) — Oncology specialists should inform patients of a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency and should test for DPYD variants before initiating treatment with capecitabine (Xeloda) and…